Barclays’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$443K Sell
13,975
-226,619
-94% -$6.18M ﹤0.01% 3257
2025
Q4
$6.53M Sell
240,594
-4,231
-2% -$111K ﹤0.01% 2011
2025
Q3
$6.33M Sell
244,825
-17,900
-7% -$415K ﹤0.01% 2012
2025
Q2
$5.35M Buy
262,725
+146,159
+125% +$2.84M ﹤0.01% 2063
2025
Q1
$2.12M Sell
116,566
-26,348
-18% -$589K ﹤0.01% 2587
2024
Q4
$3.61M Buy
142,914
+12,533
+10% +$341K ﹤0.01% 2439
2024
Q3
$4.43M Buy
130,381
+76,207
+141% +$2.9M ﹤0.01% 2191
2024
Q2
$2M Sell
54,174
-12,540
-19% -$473K ﹤0.01% 2142
2024
Q1
$2.8M Sell
66,714
-79,180
-54% -$3.25M ﹤0.01% 2288
2023
Q4
$5.79M Buy
145,894
+2,431
+2% +$71.5K ﹤0.01% 1961
2023
Q3
$3.95M Sell
143,463
-28,671
-17% -$899K ﹤0.01% 1475
2023
Q2
$5.84M Buy
172,134
+63,110
+58% +$2.13M ﹤0.01% 1262
2023
Q1
$3.92M Sell
109,024
-7,447
-6% -$321K ﹤0.01% 1715
2022
Q4
$5.19M Sell
116,471
-28,116
-19% -$1M ﹤0.01% 1592
2022
Q3
$4.06M Buy
144,587
+47,500
+49% +$1.46M ﹤0.01% 1288
2022
Q2
$2.62M Sell
97,087
-109,613
-53% -$3.18M ﹤0.01% 1665
2022
Q1
$7.04M Buy
206,700
+66,748
+48% +$2.13M 0.01% 1062
2021
Q4
$5.41M Buy
139,952
+100,184
+252% +$4.37M ﹤0.01% 1650
2021
Q3
$2.15M Buy
39,768
+17,943
+82% +$842K ﹤0.01% 2294
2021
Q2
$730K Sell
21,825
-33,474
-61% -$919K ﹤0.01% 2852
2021
Q1
$1.14M Buy
55,299
+54,799
+10,960% +$1.26M ﹤0.01% 2688
2020
Q4
$9K Sell
500
-366
-42% -$6.59K ﹤0.01% 4759
2020
Q3
$13K Buy
866
+864
+43,200% +$10.1K ﹤0.01% 4965
2020
Q2
$0 Buy
+2
New +$9 ﹤0.01% 5631
2019
Q4
Sell
-26
Closed 6384
2019
Q3
$0 Sell
26
-3,900
-99% -$9.03K ﹤0.01% 6741
2019
Q2
$10K Sell
3,926
-5,200
-57% -$17.7K ﹤0.01% 6548
2019
Q1
$45K Buy
9,126
+9,121
+182,420% +$48K ﹤0.01% 5950
2018
Q4
$0 Sell
5
-463
-99% -$2.27K ﹤0.01% 6972
2018
Q3
$3K Sell
468
-11,316
-96% -$79.2K ﹤0.01% 6874
2018
Q2
$89K Buy
11,784
+8,994
+322% +$120K ﹤0.01% 5320
2018
Q1
$97K Buy
2,790
+1,399
+101% +$54.2K ﹤0.01% 5403
2017
Q4
$59K Buy
1,391
+1,082
+350% +$46.3K ﹤0.01% 5646
2017
Q3
$13K Buy
309
+238
+335% +$8.92K ﹤0.01% 5992
2017
Q2
$2K Sell
71
-1,172
-94% -$51.8K ﹤0.01% 6405
2017
Q1
$68K Buy
1,243
+632
+103% +$32.9K ﹤0.01% 5153
2016
Q4
$32K Buy
611
+52
+9% +$2.96K ﹤0.01% 5409
2016
Q3
$33K Buy
+559
New +$34.8K ﹤0.01% 5217
2016
Q2
Sell
-2,203
Closed -$99K 6346
2016
Q1
$99K Sell
2,203
-11,245
-84% -$1.27M ﹤0.01% 4363
2015
Q4
$3.03M Buy
13,448
+11,592
+625% +$2.53M ﹤0.01% 1700
2015
Q3
$279K Buy
1,856
+1,526
+462% +$432K ﹤0.01% 3852
2015
Q2
$124K Buy
330
+144
+77% +$57.2K ﹤0.01% 4515
2015
Q1
$75K Sell
186
-2,713
-94% -$971K ﹤0.01% 5016
2014
Q4
$783K Sell
2,899
-667
-19% -$166K ﹤0.01% 3425
2014
Q3
$642K Buy
3,566
+361
+11% +$78.7K ﹤0.01% 3736
2014
Q2
$769K Sell
3,205
-1,171
-27% -$264K ﹤0.01% 3578
2014
Q1
$1.12M Sell
4,376
-4,436
-50% -$1.7M ﹤0.01% 3133
2013
Q4
$3.17M Buy
8,812
+4,141
+89% +$1.6M ﹤0.01% 2213
2013
Q3
$2.45M Buy
4,671
+3,883
+493% +$1.33M ﹤0.01% 2351
2013
Q2
$184K Buy
+788
New +$155K ﹤0.01% 5257

Other funds holding CLDX